SR One For Profit
SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care. Since 1985, SR One has invested approximately 800 million in more than 180 companies.
Invests into
%20.jpg)
Acquisitions Number:
NA
Founded Date:
1985-01-01
Headquarters:
Cambridge, Massachusetts, United States
Zip:
NA
Investors Number:
NA
Employee Number:
1-10
Industry:
Finance & Banking
Estimated Revenue:
$8.1 Million
Number Of Exists:
53
Funding Status:
N/A
Investor Type:
Corporate Venture Capital
Investment Stage:
Series A, Series C